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Abstract 
The increasing use of quantitative real-time polymerase chain reaction (qPCR) as a method for 
quantifying gene expression has led to an increased demand for standardization of data 
analysis methods to ensure accurate reporting and robust, reproducible results.  The 
exponential nature of qPCR amplification results in the potential magnification of what are 
usually very small sources of error.  Relative gene expression calculations circumvent this issue 
by normalizing target gene expression data to within-sample expression of a previously 
validated, stably expressed reference gene or genes.  Multiple studies discussed herein have 
found that qPCR data are more reliable and reproducible when multiple reference genes are 
used, and that they are validated prior to use in experiments with new conditions.  In this thesis, 
existing reference genes are evaluated to ensure they meet these criteria in experimental 
paradigms used frequently in our laboratory.  Existing work on ethanol’s anxiolytic-like effects in 
our laboratory utilized microarrays to identify Ninein as a cis-regulated, quantitative trait gene for 
these effects in nucleus accumbens (NAc) of BXD recombinant inbred mice and their 
progenitors, C57BL6/J (B6) and DBA/2J (D2) mice.  Contrasting behavioral responses to 
ethanol in these mouse strains make them a frequent subject of study for determining genetic 
components underlying those behaviors.  In the first data chapter, the case is made for 
eliminating one reference gene typically used for qPCR data normalization in qPCR 
experiments assessing strain differences in NAc gene expression in the laboratory, Ppp2r2a.  
The reference genes subsequently validated for use in qPCR analysis in ethanol-naïve NAc and 
amygdala of saline and ethanol-treated B6 and D2 mice are then used in an in-depth 
characterization of Ninein expression in B6 and D2 NAc and amygdala.  Furthermore, evidence 
is provided for the first in vivo observation of murine Ninein transcript variant 6 in adult neural 
tissue.   The data presented make the case for a more thorough re-evaluation of reference 
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genes for future qPCR experiments in the laboratory, as well as a potential mechanism for 
Ninein’s involvement in variation of anxiolytic-like responses to ethanol in B6 and D2 mice. 
  
 3
Chapter 1 Introduction and Background 
 
Neurobiology of Alcohol Use Disorders  
It has been recently estimated that 1 in every 19 people aged 12 or older in the United 
States suffer from an alcohol use disorder (AUD) (SAMHSA, 2019).  In the Diagnostic and 
Statistical Manual of Mental Disorders (APA, 2013), AUDs are characterized by persistent 
alcohol use despite negative personal, social, psychological and/or physiological consequences, 
as well as craving, tolerance, and withdrawal. Neurobiologically, increased activity in the 
mesolimbic dopamine system - including the nucleus accumbens (NAc), ventral tegmental area 
(VTA), and prefrontal cortex (PFC) - mediates the acute rewarding effects of ethanol and other 
drugs of abuse.  Neuroplasticity in these regions over a period of consistent alcohol use is 
thought to be the underlying factor in the transition from acute alcohol abuse to the chronic, 
compulsive drinking behavior seen in AUD (see Volkow & Koob, 2010 for review).  Thus, 
existing work in the laboratory has focused on the mesocorticolimbic reward circuit due to the 
extensive evidence for its role in drug reward and dependence.   
The extended amygdala also plays a key role in behavioral responses to both acute and 
chronic ethanol exposure.  The amygdala has extensive interconnectivity with the mesolimbic 
system, including afferent projections from the PFC and hypothalamus, as well as efferent 
projections to the PFC, NAc, hypothalamus, and BNST.  Changes in activity or plasticity in the 
amygdala have been associated with the rewarding effects of drugs and the preoccupation or 
craving associated with the late stages of addiction (Volkow & Koob, 2010), and acute doses of 
ethanol have been shown to alter c-Fos expression in the central amygdala and bed nucleus of 
the stria terminalis (BNST) (Davis et al., 2009; Sharko et al., 2016).   In addition, both amygdala 
and BNST have been implicated in phasic and sustained fear in both rodents and humans 
(Davis et al., 2009).  Together, these data suggest that activity in the amygdala could play a 
crucial role in the anxiolytic-like effect of ethanol.  
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Genetics of Alcohol-Related behavior 
Twin studies show that approximately 48%-58% of the liability for AUD risk is associated 
with genetic factors (Prescott & Kendler, 1999; Tawa et al., 2016).  Given the complex nature of 
AUD-related symptoms and behaviors, it is not surprising that multiple genetic loci have been 
associated with this risk (see Tawa et al., 2016 for review).  Rodent models have become one of 
the prevailing methods for studying the genetic components underlying complex ethanol-related 
behavioral phenotypes due to divergent behavioral responses to acute and chronic ethanol in 
existing inbred strains with known genotypes.  C57BL/6J (B6) and DBA2/J (D2) mice are two 
such examples of these contrasting behaviors.  In multiple chronic drinking paradigms, B6 mice 
drink more and have a greater preference for ethanol than D2 mice (Crabbe et al., 1999; 
McClearn & Rodgers, 1959; Moore et al., 2010).  B6 mice are also less sensitive to the 
locomotor activating (Phillips et al., 1994) and sedative-hypnotic (Linsenbardt et al., 2009) 
effects of ethanol, whereas D2 mice are less sensitive to ethanol's anxiolytic-like effects 
(Putman et al., 2016).  Because of their extensive behavioral characterization, B6 and D2 mice 
have been used as progenitor strains for the BXD recombinant inbred (BXD RI) line of mice, 
comprised of more than 100 inbred strains with known B6 or D2 alleles at almost 7500 
polymorphisms across all chromosomes (Taylor, 1978; Williams et al., 2001).  Correlating 
variation in genotype with variation in behavior among these strains has allowed for quantitative 
trait locus (QTL) mapping of several ethanol-related phenotypes including withdrawal (Buck & 
Finn, 2001; Crabbe et al., 1999), hypnotic sensitivity measured with loss of righting reflex 
(Radcliffe et al., 2000),  locomotor activation and motor incoordination (Demarest et al., 1999; 
DuBose et al., 2013; Phillips et al., 2010), metabolism (Grisel et al., 2002), anxiolysis measured 
in the elevated zero maze (Cook et al., 2015), and anxiolysis measured in the light-dark box 
(Putman et al., 2016).     
Associations between anxiety and alcohol use have long been reported in scientific 
literature, and patients with AUD often cite the anxiolytic properties of ethanol as the reason for 
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persistent use and abuse (Newlin & Thomson, 1990). As such, it is not surprising that pre-
existing anxiety disorders are associated with an increased risk for the onset of comorbid 
alcohol dependence (Crum et al., 2013; Swendsen et al., 2010).  With mounting evidence for 
heritable components of both AUD and anxiety disorders (Hodgson et al., 2016; Prescott & 
Kendler, 1999), our laboratory sought to identify behavioral QTL (bQTL) and expression QTL 
(eQTL) underlying the anxiolytic effect of ethanol. 
Ethanol-induced anxiolysis QTL 1 (Etanq1) was identified in nucleus accumbens using the 
BXD recombinant inbred panel of mice in the light-dark transition model of anxiety (Putman et 
al., 2016).  Light-dark transition assays rely on the innate tendency of rodents to avoid bright 
lights or open fields (Buccafusco, 2009).  In brief, a mouse is placed in a chamber with an open, 
brightly lit compartment and an enclosed dark compartment.  Increases in time spent or 
distance traveled in the light compartment after a given experimental treatment are interpreted 
as anxiolytic-like behaviors.  A mixed-model behavioral QTL analysis, incorporating the effects 
of genotype and treatment on percent distance traveled (%DTL) and percent time spent (%TSL) 
in the light after treatment with 1.8 g/kg ethanol or saline, was used to identify Etanq1 on 
chromosome 12.  Because of a potential interaction with a second QTL on Chr 1, the QTL was 
further refined using six additional BXD strains with either B6 or D2 alleles at its peak marker, 
and balanced for B6 and D2 alleles at a chromosome 1 locus with an epistatic interaction with 
Etanq1.  Differences in %DTL after ethanol treatment were still significant despite variation at 
the Chr1 locus.  Fine-mapping of the initial 18 Mb support interval, using 3 additional BXD 
strains with recombination events within Etanq1, narrowed the interval to about 3 Mb that 
includes 41 protein coding genes and genes with non-coding RNAs. Of 10 missense SNPs 
identified in this interval, the only SNP predicted to alter protein function in a deleterious manner 
(rs29159683) was within Ninein (Nin).  To determine whether BXD genotype affected mRNA 
expression, microarrays were performed with tissue from prefrontal cortex (PFC), nucleus 
accumbens (NAc), and ventral midbrain (VMB).  Genes within Etanq1 whose expression varied 
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with genotype, i.e. had cis-eQTLs, included Sos2 in VMB, and Nin, Atp5s, Trim9, and Sos2 in 
NAc.  When correlating candidate gene expression with ethanol-induced anxiolysis, only Nin, 
Sos2, and Trim9 expression in the NAc were significantly correlated with %DTL after ethanol 
injection.  Relative expression of Nin, Trim9, and Sos2 in NAc of B6 and D2 mice were 
measured using qPCR, and only Nin was differentially expressed between strains.  Allele 
specific qPCR in B6D2F1 mice revealed higher expression of mRNA containing the D2 allele, 
confirming its cis-regulation, and western blots show higher expression of two provisional NIN 
protein isoforms in D2 NAc as compared to B6 (Putman et al., 2016).  
 
Validating Quantitative Trait Genes from microarray data using quantitative real-time 
polymerase chain reaction (qPCR) 
qPCR is frequently used to validate microarray results because of its high sensitivity, 
specificity, and wider dynamic range.  In the context of quantitative trait gene (QTG) validation, 
qPCR serves as a less expensive and more rapid parallel method for evaluating expression 
differences of a smaller number of candidate genes between progenitor strains with more 
biological replicates for higher statistical power.   
There are two widely used fluorescence methods available for these purposes, namely 
SYBR Green and TaqMan technologies.  SYBR green dyes are non-specific and intercalate all 
double stranded nucleic acids.  Thus, qPCR experiments utilizing this method rely on the 
assumption that the only double stranded products in the reaction are those produced by primer 
binding to a single specific target.  In contrast, probes in TaqMan reactions contain a reporter 
fluorophore and corresponding quencher in close proximity.  During the extension phase of the 
PCR reaction Taq polymerase cleaves the probe, separating the fluorophore from the quencher 
and allowing it to fluoresce.  For this reason, TaqMan reactions are capable of amplifying 
targets with very low copy numbers, while the sensitivity of SYBR Green reactions is reliant 
upon the specificity and binding efficiency of target primers.  The utilization of different 
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fluorophores on TaqMan probes for different targets can also allow for quantification of multiple 
targets in a single reaction, which can be useful when starting RNA quantities are very low.  
Reactions with SYBR Green dyes, on the other hand, are limited to amplification of a single 
target per reaction.  The complex nature of TaqMan probes, however, are often cost prohibitive 
and frequently limited to pre-designed probes.  Primers for SYBR Green PCR are typically much 
cheaper, allowing for quick, user-based design of primers for a variety of targets.  As a result, 
SYBR Green is often the method of choice when using qPCR to quantify expression of multiple 
target QTGs. 
The primary focus of behavioral QTL and QTG validation is usually quantifying relative 
differences in expression of target genes between experimental groups.  In other words: Is the 
direction of variation in expression of the target gene directly or inversely correlated with the 
direction of variation in magnitudes of the behavior of interest? As opposed to: What specific 
copy number of a target mRNA corresponds to a specific magnitude of behavior?  In cases 
where absolute quantification is either unnecessary or not possible due to the lack of standards 
with known copy number, relative quantity (Ct method) or normalized expression (2-Ct 
method) is used.  Relative quantity is calculated as the fold change relative to either an 
"untreated" control sample or to a standard curve with serial dilutions of known cDNA mass.  
Relative quantity calculations rely on the assumption that the starting amount of cDNA template 
in all reactions is identical, which is often not the case due to small variations in quantity 
introduced during total RNA quantification prior to reverse transcription, and pipetting error 
during the setup of PCR reactions.  To compensate for this error, the 2-Ct method employs a 
previously validated internal control gene(s), or "reference gene", to normalize sample Ct values 
of target genes.  The 2-Ct method uses target gene Ct values normalized to reference gene Ct 
values to compare target gene expression in a treatment sample to an untreated control, where 
Ct is the cycle threshold of fluorescence in a given sample, Ct is the difference between target 
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gene Ct and reference gene Ct for the same sample, and Ct is the difference between the 
Cts of the treated sample and a control  (Livak & Schmittgen, 2001).   
The wide variety of RNA isolation methods, qPCR fluorophores, thermocycler protocols, and 
data analysis methods paired with the variation in reporting of validation methods and data often 
results in low reproducibility of qPCR experiments within and between labs.  As a result, the 
Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE 
Guidelines) were developed (Bustin et al., 2009).  The MIQE guidelines are recommendations 
for the submission of data collected at multiple phases of qPCR experiments prior to and after 
the actual target amplification, including experiment design, sample preparation, nucleic acid 
extraction methods, reverse transcription methods, target gene information, primer and 
reference gene validation, thermocycler protocol, reagents used, and data analysis methods.  
One of the MIQE guidelines most frequently missing from publications is the validation of 
reference genes used for normalization (Bustin et al., 2013).  The selection of appropriate 
reference genes is vital given their function in data normalization.  In order for a reference gene 
to be valid, it must be stably expressed across all experimental groups and/or tissues being 
investigated, and its amplification efficiency should be comparable to that of the target gene 
(Livak & Schmittgen, 2001).  Frequently, qPCR data are presented normalized to a single 
reference gene presumed to be stably expressed in all tissues, such as Actb or Gapdh 
(Czechowski et al., 2005).  Use of a single, non-validated reference gene can lead to the 
appearance of expression differences 3- to 6-fold higher than are actually present (Hellemans & 
Vandesompele, 2014).  Vandesompele and colleagues (2002) developed a method and 
software for calculating expression stability of candidate reference genes called GeNorm.  
GeNorm utilizes the pairwise variability of relative quantities of candidate reference genes 
between samples to designate the most stably expressed genes, as well as the minimum 
 9
number of reference genes necessary to accurately quantify target gene expression across all 
experimental groups. 
The primary goal of the work in this thesis is to find suitable reference genes for comparison 
of gene expression between in the NAc and amygdala of B6 and D2 mice treated with acute 
doses of ethanol.  Re-assessment and further characterization of Ninein expression, the 
suspected QTG underlying the QTL for ethanol-induced anxiolytic-like response to ethanol in 
mice (Etanq1), will be presented as a functional validation of the use of proper reference genes 
for qPCR experiments.  
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Chapter 2 Reassessment and Design of Reference Genes for Comparison of Gene 
Expression in B6 and D2 Mice Exposed to Acute Ethanol 
 
Introduction 
 Quantitative real-time polymerase chain reaction (qPCR) is a widely used method for 
measuring gene expression in a broad variety of cell types and tissues.  Although absolute 
quantification of target mRNA copy number is possible, it requires the availability of calibrated 
external standards with known copy number or concentration. These standards can be obtained 
from plasmids containing the gene of interest (GOI), synthetic nucleotides with the sequence of 
the amplicon desired, or cell lines with known expression levels of the GOI (see Arya et al., 
2005 for review).   This can be problematic when these resources are either unavailable or 
costly to produce, and is often unnecessary in experiments where the research question is 
based on relative expression of a GOI between treatment or time groups.  In these instances, 
measurement of relative quantities (Ct) or normalized expression(2-Ct) is used in lieu of 
absolute quantification (Livak & Schmittgen, 2001). 
The use of the Ct method for reporting gene expression is limited by the assumption 
that the amount starting quantity of template in each reaction well is equal.  Instrumental error in 
nucleic acid quantification and pipetting error often introduce small variations in starting quantity 
that render this assumption invalid.  As a result, the 2-Ct method has been widely adopted as 
an alternative.  In this method, GOI Cts in all experimental samples are normalized to reference 
gene Cts in the same samples prior to group comparisons in order to eliminate the error 
produced by small variation in starting quantities.  Reference genes in these experiments 
require prior validation of stable expression across all experimental groups, and their primers 
must have amplification efficiencies similar to GOI primers (Livak & Schmittgen, 2001).   
Because the expression level of a particular gene can vary across strains, sexes, 
tissues, cell types, and treatment groups, it is important to verify that the reference gene and 
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primers used meet both of these criteria.  When the expression level of a reference gene is very 
low, primer efficiency can be greatly impacted.  A reference gene proven to be stably expressed 
across, for instance, PFC in B6 and D2 mice with and without ethanol exposure may not be 
stably expressed in NAc under the same conditions.   Similarly, a reference gene that is stably 
expressed between strains in basal conditions may not be stably expressed in the presence of 
drug treatment, or throughout development.  Unfortunately, much of the existing qPCR literature 
utilizing reference genes for data normalization do not report validating these conditions prior to 
performing their experiments (Bustin et al., 2013).  It is also common practice to use a single 
reference gene, when in reality qPCR data normalization is typically more accurate with the use 
of at least three (Derveaux et al., 2010; Vandesompele et al., 2002). 
In an attempt to keep with these standards, this chapter describes the use of publicly 
available bioinformatic tools and published genome-wide datasets to identify candidates for use 
as reference genes in qPCR experiments comparing gene expression in B6 and D2 amygdala 
and NAc with and without an acute dose of ethanol.  This is followed by experimental validation 
of these reference genes and their primers using relative quantification and GeNorm software. 
 
Methods and Materials 
 
In-silico evaluation 
Databases, Bioinformatic Tools, and Software 
Robust Multi-array Average (RMA) values and S-scores from nucleus accumbens (NAc) 
were obtained from GeneNetwork databases GN154, GN155, GN156, containing Affymetrix 
GeneChip Mouse Genome 430 2.0 arrays from B6, D2, and BXD male mice dissected four 
hours after an IP injection with saline or 1.8g/kg ethanol (Kerns et al., 2005).  RMA values from 
basolateral amygdala were obtained from GeneNetwork database GN323, containing pooled 
Affymetrix GeneChipTM Mouse Gene 1.0 ST arrays from untreated male and female mice 
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(Mozhui et al., 2010).  Microarray data from amygdala in ethanol treated mice were not 
available. 
NCBI Primer BLAST tool was used to generate potential primer sequences, using the 
RefSeq accession number for one or all transcripts for target genes.  NCBI Nucleotide BLAST, 
UCSC in-silico PCR and UCSC BLAT tools were used to scan for overlap of mRNA and primer 
sequences in non-specific locations.  IDT UNAfold was used to evaluate the secondary 
structures of primers.  Websites for all databases and in silico tools used are listed in Table 2.1 
 
Candidate gene ID 
The genes evaluated for potential use as reference genes were pooled from an overlap 
between those used in the mouse GeNorm kit (n = 10) available from Primerdesign Ltd. 
(Camberley, UK), genes currently used as reference genes in the laboratory (n = 8), and a BXD 
gene set from microarrays in NAc filtered for ethanol S-scores between -2 and 2 and with mas4 
scores above 100 (n = 4985).   
Candidate genes from the resulting list were eliminated if: 
 B6 and D2 mice had different RMA values for that gene in NAc and/or amygdala, 
suggesting differential expression levels between the strains. 
 Either strain had a significant S-score (|S-score|>2) when comparing saline to 
ethanol-treated mice, suggesting ethanol regulates expression of the gene, 
 B6 and D2 mice had significantly different (|S-score|>2) S-scores for the target gene 
 More than 30% of the target gene sequence shared greater than 80% sequence 
identity with other genes, other gene transcripts, or non-coding chromosomal regions 
 The target gene had pseudogenes 
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Table 2.1 Websites used for bioinformatic analyses of candidate reference genes 
 
 
 
 
 
Parameter Target Value 
Product size Minimum: 70 bp  
Maximum: 400 bp 
Primer Melt Temperature Minimum: 57  
Optimum: 60 
 
Maximum: 65  
Maximum Difference: 2 
Exon junction overlap At least one primer must span an exon exon junction 
Organism ID Mus musculus (taxid: 10900) 
Primer Length Minimum: 19 bp  
Optimum: 20 bp 
 
Maximum: 25 bp 
Primer GC Content Minimum: 20% 
 
Maximum: 65% 
3' GC clamp 1 
Max Self Complementarity Any: 5.00  
3': 3.00 
Max Pair Complementarity Any: 5.00  
3': 3.00 
SNP Handling Primer binding site may not contain a known SNP 
Table 2.2 Primer design criteria 
Bioinformatics Tool URL 
GeneWeaver https://geneweaver.org/  
GeneNetwork http://www.genenetwork.org/webqtl/main.py  
NCBI PrimerBLAST https://www.ncbi.nlm.nih.gov/tools/primer-blast/  
UNAfold https://www.idtdna.com/UNAFold?  
NCBI Nucleotide BLAST https://blast.ncbi.nlm.nih.gov/Blast.cgi  
UCSC BLAT http://genome.ucsc.edu/cgi-bin/hgBlat  
UCSC in-silico PCR http://genome.ucsc.edu/cgi-bin/hgPcr?db=hg38  
NCBI RefSeq https://www.ncbi.nlm.nih.gov/refseq/  
GeNorm https://genorm.cmgg.be/  
RefSeq https://www.ncbi.nlm.nih.gov/refseq/  
 14
Primer Design 
Existing primer pairs in the laboratory were redesigned if NCBI nucleotide BLAST, 
UCSC in-silico PCR, or UCSC BLAT searches revealed one or both primers: 
 Were located in the 3'-untranslated region of a transcript 
 Did not overlap an exon junction 
 Had non-specific binding sites  
 Did not bind all known mRNA transcript variants of the given gene 
Otherwise, new primer pairs were designed with NCBI's PrimerBLAST using the default search 
parameters except for the criteria listed in Table 2.2.  Primer annealing temperature, PCR 
product length, primer length, GC content, and self-complementarity were chosen in order to 
maximize efficiency in PCR reactions using SYBR Green Master Mix.  Target mRNA specificity 
was optimized by eliminating primers that overlapped strain-polymorphisms (dbSNP) and 
requiring at least one primer to overlap an exon junction.  Potential primer secondary structures 
and their melting points were evaluated using IDT-UNAfold, and primer sequences were 
discarded if the melt temperature of those secondary structures was not significantly less than 
the predicted annealing temperature of the primer.   
 
In vivo validation 
Animals 
 Eight-week old male C57BL6/J and DBA2/J mice were obtained from Jackson 
Laboratories (Bar Harbor, ME).  Mice were housed four per cage on ventilated racks with Teklad 
Sani-Chip bedding (currently Envigo, Cumberland, VA) and cotton nesting material.  Animals 
were subject to a 12-hour light-dark cycle and had ad-libitum access to Teklad LM-485 7012 
standard rodent chow and tap water.  Two weeks after their arrival, mice were administered 
0.9% saline, 1.8 g/kg or 4 g/kg ethanol via intraperitoneal injection.  Four hours following the 
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injection, mice were sacrificed via cervical dislocation and decapitation in order to obtain brain 
tissue for dissection.  All procedures were approved by the Virginia Commonwealth University 
Institutional Animal Care and Use Committee in accordance with National Institute of Health 
guidelines. 
 
Tissue Collection 
Immediately after sacrifice, whole brains were removed and dissected as described by 
Kerns et al. (2005).  In brief, whole brain tissue was chilled for 1 minute in 1X phosphate buffer 
on ice, then dissected to isolate amygdala, nucleus accumbens, prefrontal cortex, caudate 
putamen, septum, hypothalamus, cerebellum, entorhinal cortex, and ventral midbrain.  Tissue 
sections were placed in individual tubes, flash frozen in liquid nitrogen, and stored in a -80C 
freezer until RNA extraction. 
 
Nucleic acid extraction and evaluation 
 Total RNA was isolated from amygdala and nucleus accumbens tissue as described 
previously (Kerns et al., 2005) using homogenization in STAT-60 (Tel-test, Inc., Friendswood, 
TX, USA) followed by RNA purification with a Qiagen RNeasy Mini Kit (Qiagen, Redwood City, 
CA, USA).  RNA concentration in each sample was quantified based on UV-Vis absorbance at 
260nm using a ThermoFisher Nanodrop 2000 Spectrometer. Sample quality was assessed 
using RNA Quality Indicator values acquired from analysis with a Bio-Rad ExperionTM 
Automated Electrophoresis System with Experion RNA StdSens analysis kits using the included 
protocol.  Per the Bio-Rad ExperionTM software protocol, samples with RNA quality indicator 
(RQI) values lower than 7.0 were not included in qPCR experiments. 
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Quantitative Real Time PCR (qPCR) 
cDNA was synthesized from 1g total RNA using an iScript cDNA Synthesis kit (Bio-
Rad, Hercules, CA, USA), and qPCR was performed using iQ SYBR Green Supermix Kit and 
CFX Connect Real Time System (Bio-Rad, Hercules, CA, USA).  All qPCR amplifications were 
carried out in sealed Bio-Rad hard-shell, semi-skirted, 96-well PCR plates with clear shells and 
white wells.  All reaction mixtures were 20 L; detailed parameters for each PCR experiment 
protocol can be found in the results section and Appendix 2.  In brief, for each primer pair, 
temperature gradients were carried out with one technical replicate of one sample per strain 
across a temperature range of 54C to 64C.  Optimum annealing temperature was determined 
based on gel electrophoresis experiments described below.  Standard curves were obtained 
using 3 technical replicates of one sample per region per strain in 1:5 serial dilutions with 
nuclease free water resulting in cDNA quantities of 0.04ng, 0.2ng, 1ng, and 5ng. The annealing 
temperature in the thermocycler protocol for standard curves was set to the optimum 
temperature for each primer pair as determined in temperature gradient qPCR experiments.  In 
order to obtain preliminary data, temperature gradients and standard curves were carried out 
using one biological replicate per region per strain.  In future primer validation studies, it is vital 
that at least three biological replicates per region per strain are used for robust results and 
proper quantification of limit of detection (LOD) and limit of quantification (LOQ). 
 
Gel Electrophoresis 
Optimum annealing temperature for each primer pair was determined using agarose gel 
electrophoresis.  Following qPCR, five microliters of reaction mixture from each sample at each 
temperature were run with 4% agarose and 1X GelRed (Biotium, Fremont, CA) in 1X TBE at 
90 volts.  Bands were visualized using a Kodak Image Station and Kodak 1D Image Analysis 
Software (Eastman Kodak, Rochester, NY).  Optimum annealing temperature for a primer pair 
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was selected if the run temperature of a given reaction mixture produced a single band at the 
predicted molecular weight of the product, appeared to have the highest quantity of product 
relative to other run temperatures, and had no visible bands indicating the presence of primer 
dimers at low molecular weights.  Primer pairs that did not meet all of these criteria were 
discarded. 
 
Data Analysis 
 For standard curves, Cq values were calculated using the Bio-Rad CFX Manager 3.1 
Software Single Threshold determination mode.  Cq data and standard curves were analyzed 
and plotted using Microsoft Excel 2016 for Mac.  Efficiency was calculated using the following 
equation: 
% Efficiency (E)= -1+10    ∗ 100 
 
The final candidate genes and total number of reference genes to be used were selected using 
the GeNorm macro V3.5 for Microsoft Excel previously downloaded from the GeNorm website.  
Although this version is no longer available from its originators, the updated version is included 
as part of Biogazelle's qbase+ software available at http://www.qbaseplus.com/. 
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Results 
In silico Analysis 
In silico analyses reveal five candidate reference genes. 
 Overlap analyses of the three gene sets revealed twelve genes in common between at 
least two of the sets (Figure 2.1).  In addition to these twelve genes, Ppp2r2a was included as a 
candidate gene in further bioinformatic analyses due to its use as the sole reference gene for 
previously published qPCR experiments from our laboratory.  This resulted in a total of thirteen 
genes used in the following bioinformatic analyses of candidate reference genes. 
Reference genes (n=13) were evaluated for potential use in experiments comparing 
nucleus accumbens in B6 and D2 male mice exposed to saline or 1.8 g/kg ethanol, and 
amygdala from ethanol-naïve animals.  As a preliminary screen, available nucleus accumbens 
microarray data from previously published experiments (Kerns et al., 2005) were examined for 
evidence of differential expression of candidate genes (n=13) between strains and ethanol dose 
group.  The results of this analysis are summarized in Table 2.3 and Table 2.4.  One Actb 
probeset located in the last two exons of the transcript indicated differential regulation of Actb by 
ethanol between B6 and D2 mice in nucleus accumbens (|SscoreDBA/2J – SscoreC57BL/6J| > 2). 
Available RMA values from microarrays in ethanol-naïve B6 and D2 mice indicate no difference 
in basal expression of any of the thirteen genes in amygdala(Mozhui et al., 2010). 
 Candidate genes (n=13) and their associated transcripts (n=27) were assayed for 
sequence similarity with unintended targets using the BLASTn algorithm.  Of the original 13 
candidate genes, five were eliminated due to overlap of their gene sequences with non-specific 
transcripts or chromosomal areas, while an additional three were eliminated because one or 
more of their transcript variants overlapped non-specific targets.  This resulted in a list of five 
candidate genes remaining: B2m, Canx, Ndufv1, Sdha, and Sort1.  None of these had 
pseudogenes.  The workflow used and its results are shown in Figure 2.2. 
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Primer design 
The laboratory had previously designed primers for four out of five of the final candidate 
genes – B2m, Canx, Ndufv1, and Sort1.  In order to avoid binding of primers to parent gene loci 
on potential genomic DNA contamination of samples, primer pairs were discarded if neither 
primer overlapped an exon junction or one of the primers was located in the 3'-untranslated 
region of a target transcript.   Existing primers for B2m were the only primers that did not require 
redesign based on these criteria.  New primers for Canx, Ndufv1, Sort1, and Sdha were 
designed using NCBI PrimerBLAST, and subsequently evaluated using UCSC in-silico PCR, 
UCSC BLAT and/or NCBI BLAST, and IDT-UNA Fold.  The alignment of all primers to their 
target mRNAs are shown in Figure 2.3 and Figure 2.4; primer sequences are listed in Table 2.5. 
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Figure 2.1 Overlap of Candidate Reference Gene Sets 
Sets of genes from our laboratory (n=8), GeNorm kits (n=10), and an analysis of nucleus 
accumbens (NAc) microarray data from our laboratory filtered for genes with high expression 
levels (RMA values greater than 6.64) and no differential expression with acute ethanol 
exposure (within-strain saline vs. 1.8g/kg ethanol |Sscores|<2) (n=4985). 
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Gene 
Symbol 
ProbeSetID / RecordID ProbeTarget 
Saline RMA Ethanol RMA 
Ethanol vs Saline 
Sscore 
C57BL/6
J 
DBA/2
J 
C57BL/6
J 
DBA/2
J 
C57BL/6J DBA/2J 
Actb 
1419734_at mid 3' UTR 10.277 10.299 10.255 10.153 -0.053 -0.714 
1436722_a_at exon 3, 4, 5 and proximal 3' UTR 14.491 14.306 14.556 14.302 0.814 -0.729 
AFFX-b-
ActinMur/M12481_3_at 
last two exons (Affymetrix control, 3'-most probe set used to calculate 3':5' 
ratio) 
14.526 14.422 14.589 14.346 1.120 -1.160 
AFFX-b-
ActinMur/M12481_M_at 
exon 3 (Affymetrix control, middle probe set used to compute 3':5' ratio) 13.911 13.659 13.956 13.665 0.955 -0.661 
AFFX-b-
ActinMur/M12481_5_at 
exons 2 and 3 (Affymetrix control, 5'-most probe set used to calculate 3':5' 
ratio) 
14.036 13.780 14.081 13.805 1.018 -0.377 
Atp5b 1416829_at exons 8 and 9 14.144 14.109 14.109 14.114 0.140 -0.372 
B2m 
1427511_at first intron 5.773 5.779 5.817 5.737 0.461 0.150 
1452428_a_at two exons 11.047 10.896 11.057 10.919 0.046 0.404 
1449289_a_at last two exons and 3' UTR 11.052 10.898 11.035 10.979 -0.168 1.056 
Canx 
1445045_at NA 4.992 5.032 5.006 5.049 -0.089 -0.274 
1428935_at NA 8.775 8.737 8.784 8.672 -0.228 -0.684 
1415692_s_at mid 3' UTR 12.380 12.382 12.300 12.430 -0.348 0.265 
1422845_at last exon and proximal 3' UTR 10.972 10.874 10.809 10.995 -1.073 0.719 
Eif4a2 1450934_at last exon and 3' UTR 13.856 13.880 13.821 13.883 0.293 -0.465 
Ndufv1 
1456015_x_at last exon and 3' UTR 11.987 12.076 12.011 12.064 0.464 -0.181 
1415966_a_at last exon 12.274 12.370 12.296 12.397 0.307 0.047 
1415967_at exons 7, 8, and 9 (of 10) 12.181 12.270 12.186 12.256 0.365 -0.187 
Ppp2r2
a 
1429715_at NA 8.088 8.078 8.092 8.078 -0.273 -0.024 
1437730_at NA 12.097 11.940 12.065 11.900 0.079 -0.647 
1453260_a_at last exon and last intron 10.998 10.773 10.944 10.825 -0.026 0.495 
Rpl13a 
1433928_a_at NA 10.789 10.942 10.809 10.977 0.108 0.280 
1455001_x_at NA 11.659 11.730 11.736 11.759 0.682 -0.293 
1455485_x_at last three exons 13.888 13.842 13.947 13.848 0.794 -0.196 
1435873_a_at last two exons 13.841 13.832 13.915 13.840 0.892 -0.055 
1417608_a_at exons 3 and 4 13.302 13.236 13.324 13.238 0.905 0.300 
Table 2.3 Nucleus Accumbens Microarray Data for Candidate Reference Genes 
The Actb probe highlighted in red shows differential regulation by ethanol in B6 and D2 mice. 
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Gene 
Symbol 
ProbeSetID / RecordID ProbeTarget 
Saline RMA Ethanol RMA Ethanol vs Saline Sscore 
C57BL/6J DBA/2J C57BL/6J DBA/2J C57BL/6J DBA/2J 
Sdha 
1426689_s_at mid-distal 3' UTR 12.012 12.066 12.015 12.033 0.172 -0.301 
1426688_at last two exons and proximal 3' UTR 12.496 12.481 12.497 12.503 0.277 -0.062 
1445317_at intron (not expressed) 7.600 7.481 7.655 7.400 0.278 -0.045 
1433293_at intron 1 (expressed) 8.686 8.671 8.807 8.656 0.934 0.318 
Sort1 
1423363_at proximal 3' UTR 9.480 9.190 9.339 9.452 -0.800 1.069 
1450955_s_at proximal 3' UTR 9.450 9.198 9.307 9.449 -0.579 0.992 
1423362_at distal 3' UTR 11.856 11.817 11.794 11.811 -0.465 -0.252 
Ubc 
1432827_x_at only coding exon 13.946 14.030 13.949 14.069 0.330 -0.124 
1420494_x_at only coding exon and 3' UTR 13.433 13.457 13.485 13.513 0.676 0.134 
1425966_x_at only coding exon and 3' UTR 12.196 12.205 12.206 12.233 0.113 0.109 
1437666_x_at only coding exon and 3' UTR 13.486 13.507 13.503 13.531 0.763 -0.128 
1425965_at NA 7.721 7.600 7.649 7.577 -0.186 -0.541 
1438137_at NA 6.971 7.050 7.039 7.065 0.914 -0.444 
1458507_at NA 7.332 7.509 7.443 7.479 0.113 -0.043 
Ublcp1 Data Not Available 
Ywhaz 
1416103_at far 3' UTR 10.592 10.596 10.604 10.566 -0.110 0.125 
1436971_x_at distal 3' UTR 13.694 13.703 13.681 13.702 0.352 -0.336 
1448218_s_at mid distal 3' UTR 13.189 13.191 13.096 13.157 -0.179 -0.557 
1439005_x_at multiple probe targets (antisense to human Ywhaz sequence) 10.293 10.092 10.262 10.040 0.076 -0.126 
1436981_a_at antisense probe set in mid 3' UTR of Ywhaz (LTR element homology) 10.981 10.905 11.059 10.856 0.499 -0.008 
1416102_at mid-proximal 3' UTR 12.626 12.479 12.520 12.557 -0.341 0.012 
1448219_a_at mid 3' UTR 13.411 13.237 13.328 13.297 -0.235 -0.073 
1443893_at intron 2 5.354 5.325 5.432 5.399 -0.161 -0.068 
 
Table 2.4 Nucleus Accumbens Microarray Data for Candidate Reference Genes (continued)
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Figure 2.2 Workflow for Candidate Gene Selection 
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In vivo validation 
RNA Sample Quality  
Canx, Sort1, and Ndufv1 primers were analyzed first due to their immediate availability.  
Ppp2r2a and Ublcp1 were also evaluated because of their broader applicability to ongoing 
experiments in the laboratory.  RNA sample quality for B6 and D2 amygdala and nucleus 
accumbens was assessed prior to any qPCR experiments.  Figure 2.5 shows the virtual gel 
electrophoresis images and resulting RNA quality indicator (RQI) numbers from Experion runs 
of the four samples used to produce temperature gradients and standard curves.  
Primer evaluation  
Annealing temperatures of primer pairs were evaluated using a 3-step qPCR protocol 
with a plate temperature gradient spanning 10C and centered around the predicted melt 
temperature of the primers as the annealing step. In order to reduce the number of agarose gels 
run, qPCR products from sample reactions at the annealing temperature with the lowest Cq and 
no-template control reactions at the lowest annealing temperature were evaluated.  Primer pairs 
Ublcp1 F/R2, and Ublcp1 F/R3, were discarded because more than one distinct band was 
visible in the sample qPCR products (Figure 2.6).  Standard curves were produced with 
samples from one B6 and one D2 mouse using the annealing temperature with the lowest Cq 
from remaining primer pairs for all genes except Canx and Sort1.  Efficiency and R2 were 
determined for each strain and brain region separately (Figure 2.7).  Ndufv1 F/R2 primers were 
excluded from further analyses in amygdala because both efficiencies were not between 80-
100%.  The remaining primers (Canx F/R3, Sort1 F/R2, Ppp2r2a F/R, and Ublcp1 F/R4) were 
used in subsequent experiments evaluating candidate reference genes in amygdala.  Canx 
F/R3, Sort1 F/R2, Ndufv1 F/R2, and Ublcp1 F/R4 were evaluated in NAc. 
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Figure 2.3 New and Existing Primer Alignments 
Primers are displayed as two arrows flanking the intended amplicon.  The direction of the arrow indicates the direction of the primer.  
Primers or amplicons highlighted in red indicate that they did not meet primer design criteria. 
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Figure 2.4 New and Existing Primer Alignments (continued) 
Primers are displayed as two arrows flanking the intended amplicon.  The direction of the arrow indicates the direction of the primer.  
Primers or amplicons highlighted in red indicated that they did not meet primer design criteria. 
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Existing Primers 
Target Gene Primer Pair Name Forward Primer (5' to 3') Reverse Primer (5' to 3') 
B2m B2m F/R1 GGAGAATGGGAAGCCGAACA TCTCGATCCCAGTAGACGGT 
Canx Canx Fwd/Rev TGGCAGTCAAGATGAGGAAG GAAGGGGAGGGAGAGGAAAT 
Ndufv1 Ndufv1 Fwd/Rev GACCGTGCTAATGGACTTCG GGCATCTCCCTTCACAAATC 
Sort1 Sort1 Fwd/Rev TTTATCAGTATGCCCCGAAT CCATCAAACACAGGGACTCA 
Ublcp1 Ublcp1 F2/R2 GCTAAAATGAAAGAGCTGGGCG ACACCAAGAGGCTTCACGTC 
New Primers 
Target Gene Primer Pair Name Forward Primer (5' to 3') Reverse Primer (5' to 3') 
Canx 
Canx F2/R2 CAGATGACTGGGATGAAGACGC TTCCTTGGTTTCCAGATTCCCTG 
Canx F3/R3 GCTTTGCCAGTGTTCCTTG ATTTCATCCTCCTCTGCTTTAGG 
Ndufv1 Ndufv1 F2/R2 ATGTGTTTGTGGTGCGTGGG GGCATCCAAACACTCCCACATC 
Sdha Sdha F1/R1 AACTACAAGGGACAGGTGCTG CCTCCCCACAGGCATACAG 
Sort1 Sort1 F2/R2 CTCTATACCACCACAGGCGG GAAGGCTGCACTCGTTCTTG 
Ublcp1 
Ublcp1 F3/R3 AATGAAAGAGCTGGGCGTGA CCCAAATGACACCAAGAGGC 
Ublcp1 F4/R4 TCCTGGTGCTGGATGTTGAC TCACGCCCAGCTCTTTCATT 
Table 2.5 New and Existing Reference Gene Primer Sequences 
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Strain Region 
Sample 
Name 
RNA 
Area 
RNA 
Concentrati
on (ng/𝛍L) 
Ratio 
[28S:18S] 
RQI 
RQI 
Classification 
D2 NAc 9084N 20.48 152.02 1.33 9.4  
D2 Amygdala 9084A 50.96 59.91 1.57 8.9  
B6 NAc 9071N 148.34 74.15 1.17 8.8  
B6 Amygdala 9071A 65.49 32.74 1.14 9.3  
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Figure 2.5 RNA Quality Asessment of Samples Used for Standard Curves 
a) Virtual gel image from NAc and amygdala of a B6 mouse 
b) Virtual gel image from NAc and amygdala of a D2 mouse 
a) b) 
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Canx and Sort1 are optimum reference genes to use in experiments evaluating gene expression 
in ethanol dose-response experiments with B6 and D2 mice  
Variability in expression of candidate reference genes was examined in amygdala from 
B6 and D2 mice i.p. injected with 0 g/kg, 1.8 g/kg, or 4 g/kg ethanol (n = 7-8 per group).  Mean 
Cq values for each gene in amygdala are shown in Figure 2.8.  No significant differences were 
found between experimental groups for any of the genes in amygdala (two-way ANOVA, α = 
0.05).  GeNorm analysis of these results determined the optimum number of reference genes to 
be 2-3 (V2/3 = 0.121, V3/4 = 0.189) and Canx and Sort1 to have the lowest amount of variability in 
expression across experimental groups among the genes tested (M = 0.345, Figure 2.10).  In 
NAc from saline treated B6 and D2 mice, no significant differences were found between Mean 
Cq for any of the genes studied (Figure 2.9); the most stable genes were Canx and Ublcp1 
(Figure 2.11). 
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Ubclp1 FR3; 131 bp 
Ubclp1 FR2; 128 bp 
Figure 2.6 Gel electrophoresis of Ublcp1 primer products 
Red arrows show location of potential unintended product.  N = 
nucleus accumbens, A = amygdala. Note: The ladder and samples 
shown in each image were run on the same gel.  The whole gel 
images have been cropped to remove wells with samples from 
unrelated experiments 
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Figure 2.7 Standard Curves for Candidate Reference Genes in NAc and Amygdala 
 
Mean Cq ± SEM of three technical replicates of one sample per strain in each brain region.
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Figure 2.8 Mean Cq of Candidate Reference Genes Across Ethanol Doses and Strains In 
Amygdala 
Data are presented as mean ± SEM (n=6-8 per group). No significant differences were identified 
with two-way ANOVA with Tukey's post-hoc tests (α = 0.05). 
  
Target
Canx FR3
Dose
0 g/kg 1.8 g/kg 4 g/kg
C
q 
M
ea
n
20
25
30
35
Ppp2r2a
0 g/kg 1.8 g/kg 4 g/kg
Sort1
20
25
30
35
Ublcp1 FR4
Strain
B6
D2
 33
 
Figure 2.9 Mean Cq of Candidate Reference Genes in Saline-treated B6 and D2 Nucleus 
Accumbens 
Data are presented as mean ± SEM (n=6-8 per group). No significant differences were identified 
with two-way ANOVA with Tukey's post-hoc tests (α = 0.05) 
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Figure 2.10 GeNorm Ranking of Most Stable Reference Genes in Amygdala 
Average expression stability values of candidate reference genes in amygdala (n=46) from B6 and D2 
mice exposed to saline, 1.8g/kg ethanol, or 1.4 g/kg ethanol. 
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Figure 2.11 GeNorm Ranking of Most Stable Reference Genes in Nucleus Accumbens 
Average expression stability values of candidate reference genes in nucleus accumbens (n=14) from 
saline treated B6 and D2 mice 
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Discussion 
 
 Prior to the evaluation and collection of the data presented in this chapter, the most 
commonly used reference genes to evaluate target gene expression in NAc and other brain 
regions of ethanol treated B6 and D2 male mice in our laboratory were Ppp2r2a and Ublcp1.  
These genes and their primers were chosen based on prior experiments validating their use as 
reference genes in ventral midbrain samples (Megan O’Brien, Miles laboratory; data not shown).  
In light of the developing standards for reference genes proposed by (Vandesompele et al., 
2002), and in an effort to comply with MIQE guidelines (Bustin et al., 2009), new and existing 
laboratory reference genes were assessed for use in future experiments in both amygdala and 
NAc of B6 and D2 mice.  Of the 13 genes initially considered, only B2m, Canx, Ndufv1, Sdha, 
and Sort1 met all of the in-silico criteria used for selection of optimum candidates.   Primers 
were then designed and validated in B6 and D2 NAc and amygdala using melt curves and 
standard curves to determine efficiency.      
 Based on GeNorm analyses, Canx and Sort1 were the two genes with the least 
variability in amygdala of B6 and D2 mice from an acute ethanol dose-response experiment.  At 
a minimum, these two reference genes should be used in further qPCR experiments comparing 
gene expression in amygdala from ethanol treated mice of these strains, followed in order by 
Ublcp1 and Ppp2r2a.  In NAc, candidate reference genes were only evaluated from saline-
treated B6 and D2 mice.  For experiments comparing basal gene expression in NAc of B6 and 
D2 mice, Ublcp1 and Sort1 are the most stably expressed between strains, followed in order by 
Canx and Ndufv1.  Any comparison of B6 and D2 gene expression in NAc involving ethanol 
exposure will require further evaluation of candidate reference gene stability under those 
conditions.   
It is important to note that Ppp2r2a was not present in the NAc microarray data from 
saline and ethanol treated BXD strains filtered for genes that were not differentially regulated by 
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ethanol (Kerns et al., 2005), particularly because of its use as the sole reference gene in 
previous experiments in NAc of B6 and D2 mice in the laboratory.  In fact, qPCR data from 
ethanol-naïve B6 and D2 NAc suggests Ppp2r2a could be differentially expressed between the 
strains (Figure 2.12).  Furthermore, ~50% of each of four Ppp2r2a transcript variants has 
greater than 90% sequence homology with a non-coding area of Chromosome 12, which makes 
it very difficult to design primers that will bind specifically to cDNA from Ppp2r2a transcripts in 
the presence of genomic DNA contamination.  This would be less of an issue if total RNA 
samples were DNAse-treated prior to reverse transcription, but unless that is a laboratory-wide 
practice, target sequence similarity with genomic DNA needs to be considered when designing 
primers.  Regardless, because of the apparent differential expression of Ppp2r2a in B6 and D2 
NAc under basal conditions, it is the recommendation of the author that Ppp2r2a no longer be 
used as a reference gene in NAc for comparison of B6 and D2 gene expression.   Similarly, 
existing qPCR experiments comparing gene expression in B6 and D2 NAc that use Ppp2r2a as 
a reference gene should be repeated with appropriately validated reference genes. 
 The difference in Ndufv1 primer efficiency between NAc and amygdala in both strains, 
and the apparent differential expression between strains of Ppp2r2a in NAc, but not amygdala 
highlights the need for validation of reference genes as well as their primers for any experiments 
with new or unique conditions.  Ndufv1 may be stably expressed in amygdala, but the low total 
expression level of this gene makes that impossible to quantify in this region.  Consequently, 
reference gene primers validated in one experimental condition (in this case, brain region) may 
not be appropriate for another.   Conversely, the elimination of a candidate reference gene 
because of variability between groups in one experiment does not preclude its use in a different 
experiment where, for example, the same strains are used but a different brain region is being 
examined.  Perhaps the most important conclusion gathered from this work is that accurate 
reporting of gene expression differences using relative quantification in qPCR requires 
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evaluation of multiple reference genes across all groups for the specific experimental 
paradigm being used. 
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Figure 2.12 Ppp expression in NAc Normalized to Ublcp1 
 
Data are presented as mean ± SEM (n=4 per strain). Pstudent's-t = 0.45
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Chapter 3 Ninein Characterization as a Functional Validation of the Use of Proper 
Reference Genes 
 
Introduction 
Ninein was identified by our laboratory as a quantitative trait gene for ethanol induced 
anxiolytic-like behavior in BXD mice.  Ninein is a microtubule associated protein (MAP) typically 
found at the minus end of microtubules in the centrosome, but has recently been identified in 
the cytoplasm of all parts of embryonic cortical neurons in mice, playing a role in axon outgrowth 
and branching (Srivatsa et al., 2015).  There are 3 known NIN protein isoforms, and 6 known 
Nin transcript variants in mice (Table 3.1).  The D2 allele at a potentially deleterious SNP 
(rs29159683) and another missense SNP (rs29192398) in these variants results in the creation 
or alteration of an exon splice enhancer sequence that promotes the splicing of exon 18 
(RefSeq NR_104397.2).  The absence of exon 18 has been shown to result in the dissociation 
of NIN peptides from the centrosome, and the presence of another exon (exon 29) results in 
diffusion of NIN peptides throughout the cytoplasm.  Perhaps more striking, NIN peptides 
translated from these alternatively spliced variants are present almost exclusively in 
differentiated neurons (Zhang et al., 2016).  In NCBI’s current genome assembly, Nin transcript 
variants containing exon 29 are labeled non-coding because the presence of this exon creates a 
downstream frameshift resulting in a ‘premature’ stop codon, making these transcripts 
suspected targets for nonsense-mediated mRNA decay.  While the stop codon present in 
transcript variants containing exon 29 is upstream of stop codons in other variants, the findings 
of Zhang et al. suggest that the resulting protein is not dysfunctional, but rather localizes 
differently than other isoforms.  This may be problematic in mitotic cells where the primary 
function of NIN is in the centrosome, but non-deleterious in post-mitotic cells such as neurons 
where the stability of microtubules in or near dendritic spines plays an integral role in synaptic 
plasticity.   
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The provisional proteins NIN4 and NIN5 (see figure 7c in Putman et al. 2016), that were 
differentially expressed in NAc of B6 in D2 mice, have molecular weights corresponding to the 
predicted protein products of Nin transcript variants 5 and 6, containing exon 29.  However, as 
of the time of this writing, there is no evidence for the presence of either of these transcripts in 
amygdala or nucleus accumbens of B6 or D2 mice in vivo. 
 In this chapter, basal expression of specific Nin transcript variants is examined in both 
nucleus accumbens and amygdala of B6 and D2 mice using appropriately selected reference 
genes from the previous chapter.  The aim of these experiments is to validate the use of proper 
reference genes while providing a structural/functional basis for the role of Ninein in Etanq1-
related behaviors. 
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Primer Set 
Exon(s) 
Amplified* 
Variant(s) 
Targeted 
Protein Product Functional Significance 
Tissue 
Presence 
NinEx5,6,7 5,6,7 All Varies Varies Varies 
NinEx16,1
7 
16,17 
("large exon") 
1-5 Varies Localizes Nin to centrosome 
Somatic, 
Nervous 
NinTV1  1 NIN isoform 1 
Microtubule anchoring at 
centrosome 
Somatic, 
Nervous 
NinTV2,3  2,3 NIN isoform 2 
Microtubule anchoring at 
centrosome 
Somatic, 
Nervous 
NinTV4  4 NIN isoform 3 
Microtubule anchoring at 
centrosome 
Somatic, 
Nervous 
NinTV5,6 29 5,6 Unknown 
Peptides localize away from 
centrosome; 
Neurons 
NinTV6 
Absence of 
"large exon" 
6 Unknown 
Peptides localizes away from 
centrosome AND throughout 
cytoplasm 
Neurons 
Table 3.1 Targeted Ninein transcript variants and protein isoforms
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Methods and Materials 
Experimental Subjects 
C57BL/6J (n=8) and DBA/2J (n=8) male mice were obtained at 8 weeks of age from 
Jackson Laboratories (Bar Harbor, ME) and housed 4 per cage on ventilated racks with Teklad 
Sani-Chip bedding and cotton nesting material.  All animals had ad libitum access to Teklad LM-
485 7012 standard rodent chow and water under a 12-hour light-dark cycle.  After two weeks, 
animals were sacrificed via cervical dislocation followed by decapitation. Immediately following, 
whole brains were removed and dissected as described in Kerns et. al, 2005. Tissue sections 
were placed in individual tubes, flash frozen in liquid nitrogen, and stored in a -80C freezer until 
further use.  All experimental procedures were approved by Virginia Commonwealth University 
Institutional Animal Care and Use Committees in accordance with NIH guidelines.   
 
Nucleic acid extraction and evaluation 
 Total RNA was isolated from amygdala tissue as described previously (Kerns et al., 
2005) using homogenization in STAT-60 (Tel-test, Inc., Friendswood, TX, USA) followed by 
RNA purification with a Qiagen RNeasy Mini Kit (Qiagen, Redwood City, CA, USA).  RNA 
concentration in was quantified based on UV-Vis absorbance at 260nm using a ThermoFisher 
Nanodrop 2000 Spectrometer. Sample quality was determined using RNA quality indicator 
(RQI) values acquired from a Bio-Rad ExperionTM Automated Electrophoresis System with 
Experion RNA StdSens analysis kit.  Samples with RQI values lower than 7.0 were not included 
in qPCR experiments. 
 
qPCR 
cDNA was synthesized from 500 ng total RNA using Bio-Rad iScript cDNA Synthesis Kit.  
RT-qPCR was performed using Bio-Rad Universal SYBR Green Supermix in conjunction with 
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Bio-Rad CFX Connect Thermocycler. Bio-Rad CFX Manager Software was used for calculation 
of Cq values and relative normalized expression.  Cqs were determined using the single 
threshold method, and relative normalized expression was determined using ΔΔCq method with 
two reference genes: Ublcp1 and Canx.  Target gene and transcript primers were designed and 
validated using the same procedure described in 0.  Specific primer sequences can be found in 
Appendix 2. 
 
PCR Product Isolation and Sequencing 
Following qPCR, reaction mixture from one amygdala sample containing primers that 
would amplify Nin transcript variant 6 was run with 4% agarose and 1X GelRed (Biotium, 
Fremont, CA, USA) in 1X TBE at 90 volts.  Bands were visualized using a Kodak Image Station 
and Kodak 1D Image Analysis Software (Eastman Kodak, Rochester, NY).  The resulting band 
corresponding to the predicted molecular weight of an exon-18-lacking product was isolated 
using a QIAquick Gel Extraction Kit (Qiagen, Redwood City, CA, USA).  Purified qPCR product 
and transcript variant 6 qPCR primers were sent to Eurofin Genomics DNA sequencing services 
(Louisville, KY, USA) for sequencing.  The resulting sequence overlap was analyzed using 
NCBI Nucleotide BLAST. 
 
Statistical Analyses 
All statistical analyses were performed using JMP Pro 13 statistical software (SAS, Cary, 
NC, USA).  Strain-mean relative normalized expression for each gene was compared using 
student’s t-tests, and groups were considered significantly different if p<0.05. 
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Results 
 
Functional validation of reference genes for measuring basal gene expression in B6 and 
D2 mice 
 
qPCR was used to compare two reference genes in nucleus accumbens (NAc) of 
ethanol-naïve B6 and D2 male mice.  Figure 3.1a shows the mean Cq values for Actb and 
Ublcp1 in these samples.  Although the strain-mean Cq difference does not reach statistical 
significance (p=0.3081, student's t-test), the variability of Actb expression between both mouse 
strains results in the appearance of otherwise non-existent strain differences in expression of a 
target transcript, Ninein transcript variant 1 (NinTV1), when it is used as a reference gene.  
Figure 3.1b shows the same NinTV1 qPCR data (Cq) normalized to Actb, both Actb and Ublcp1, 
and Ublcp1 alone.  The significant difference in expression between strains observed when Actb 
is used as a reference gene alone (p=0.0016), and paired with Ublcp1 (p<0.0001), is no longer 
evident when Ublcp1 is used as the sole reference gene (p=0.3002).  In addition, when Actb is 
paired with Ublcp1 the M-value reflecting pair-wise reference gene stability is higher than the 
recommended value for heterogenous samples (MActb/Ublcp1 = 1.2063).  Further, a two-way 
ANOVA revealed a significant effect of reference gene(s) used (p=0.0003) and a significant 
interaction of reference gene(s) used with strain effect (p=0.0069) on relative normalized 
NinTV1 expression.  The significance of this interaction is eliminated when examining target 
genes that exhibit much larger differences in expression between strains, as is the case with 
Stab2 (Figure 3.1c, preference gene(s)=0.6796, pstrain<0.0001, pinteraction=0.5539). 
 
Detailed characterization of Ninein expression in B6 and D2 mice 
Basal expression of all six Nin transcript variants, exons of interest, and total Nin 
expression was also examined via qPCR in nucleus accumbens and amygdala.  Basal 
expression of these targets normalized to Ublcp1 in nucleus accumbens is shown in Figure 
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3.2a.  Nin transcript variant 4 is the only transcript with significant differences in expression 
between strains in NAc (p=0.02638).  Additionally, total Nin, transcript variants 2 and 3 together, 
and transcript variants 5 and 6 together had near significant differences in expression in nucleus 
accumbens (pTotalNinein=0.0649, pNinTV2,3=0.0890, pNinTV5,6=0.0886).  In all cases, expression of 
these transcripts was higher in D2 NAc than B6 NAc.  Of particular importance is the 
amplification of transcript variants 5 and 6, which have not been previously observed in this 
brain region in vivo in adult mice.  
After seeing amplification of Nin transcript variants 5 and 6 in NAc, new primers were 
designed specifically to target transcript variant 6 in amygdala.  The forward primer of this set 
overlapped the junction between the exon immediately upstream and immediately downstream 
of the "large exon" present in Nin transcripts 1-5.  This exon is responsible for the localization of 
Ninein at the centrosome, and its absence results in re-localization of Ninein away from the 
centrosome in neurons in vitro (Yu et al., 2009; Zhang et al., 2016).  As of this writing, we are 
aware of no published record of this transcript found in vivo in amygdala in adult mice.  
Expression of the large exon in Ninein and transcript variants 1, 4, 5, and 6 normalized to Canx 
and Ublcp1 is shown in Figure 3.2b.  Significant differences between strains were found for 
NinTV1 (p=0.0028) and NinTV5,6 (p=0.0024).  NinTV6 primers amplified a product in both 
strains, and while there was a small difference between strains it did not reach statistical 
significance (p=0.2827).  The product of this reaction was isolated and sequenced; its sequence 
overlap with Nin transcript variants is shown in Figure 3.3.  NCBI's BLAST algorithm identified a 
99% overlap, including one mismatch and zero gaps, with 100% of the sequenced PCR product 
with the intended NinTV6 target.  The next five closest matches are with NinTVs 1-5 in regions 
that share exons with NinTV6 downstream of the junction covered by the forward primer.   
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Figure 3.1 Actb1 and Ublcp1 as Reference Genes for B6 and D2 Nucleus Accumbens 
Data are presented as strain-mean ± SEM.  a) Strain-mean Cq of Actb and Ublcp1 in nucleus accumbens. No significant differences were 
observed using student’s t-test (α=0.05).  b) and c) Comparison of expression of NinTV1 and Stab2 normalized to Actb alone, Actb and 
Ublcp1, and Ublcp1 alone.  Significance determined using two-way ANOVA with Tukey’s post-hoc tests (α=0.05).  *p<0.05, **p<0.01, 
****p<0.0001. 
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Figure 3.2 Characterization of Ninein Expression in Nucleus Accumbens and Amygdala 
Strain means ± SEM of relative normalized expression of Ninein exons and transcript variants.  
Significant differences determined using student’s t-tests with α=0.05.  *p<0.05, **p<0.01, ~p<0.1 
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Figure 3.3 Sequenced PCR Product Overlap with Nin Transcript Variants 
The PCR product isolated from PCR in B6 amygdala uniquely overlaps the sequence of NinTV6, which excludes the "large exon" 
responsible for localization of NIN to the centrosome.  Thick blue bars represent exons, while thin arrowed lines represent introns.  It 
should be noted that due to limitations in the ability to incorporate multiple features in the file type necessary to display these images, 
that the single mismatch present at chr12:70055152 is not shown in this diagram. 
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Discussion and Future Directions 
 
Proper selection of reference genes for a particular qPCR experiment is vital for 
obtaining accurate results.  In the case of Ninein in B6 and D2 nucleus accumbens and 
amygdala, quantifying differences in expression of specific exons or transcripts requires the 
ability to detect very small differences in target quantities.  When comparing Actb and Ublcp1 as 
reference genes in nucleus accumbens it is clear that, despite the lack of statistical significance, 
higher variability in expression of a reference gene such as Actb greatly alters the appearance 
of strain differences in expression of Ninein transcript variant 1.  This is true even when paired 
with Ublcp1, which has less variability in mean Cq across strains.  On the other hand, small 
variability in reference gene expression across experimental conditions is less relevant when 
observing targets with very large differences in expression. For example, in the case of Stab2, 
the change in expression between B6 and D2 mice is apparent regardless of the reference 
gene(s) used for normalization.  Identifying small differences in gene expression will be crucial 
in ethanol-related behavioral experiments where the differences in single gene expression are 
often less than 30%, and the response of the network of genes that are co-regulated with a GOI 
likely contributes more to a given behavioral phenotype than the GOI alone (Kerns et al., 2005; 
van der Vaart et al., 2017; Wolen et al., 2012). 
Interestingly, the Bio-Rad CFX Manager software used for calculating normalized 
expression of targets relative to reference genes shows a higher coefficient of variance (CV) for 
Ublcp1 compared to Actb, which suggests higher variability in Ublcp1 expression across 
samples.  This is notable because, when looking at the mean Cq data, the standard deviation of 
mean Cq of Ublcp1 across all samples (0.536) is almost three-fold less than that of Actb 
(1.461).  It is also clear in the comparisons shown in Figure 3.1b that the inclusion of Actb as a 
reference gene dramatically changes the conclusions that can be drawn from looking at 
normalized gene expression data. This discrepancy highlights the need for careful examination 
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of data and calculations produced by qPCR analysis software, rather than a blind reliance on its 
output.  Perhaps more importantly, this further illustrates the need for validation of more than 
two potential reference genes when normalized expression is to be used as the primary metric 
for comparing target gene expression across experimental conditions.  Because the analysis of 
Ninein in nucleus accumbens was done prior to the evaluation of multiple other reference 
genes, Actb and Ublcp1 were run based on their previous use for similar experiments in the 
laboratory.  qPCR data regarding detailed nucleus accumbens Nin characterization in this 
chapter are presented normalized only to Ublcp1.  Future experiments aiming to reproduce or 
expand upon these results in nucleus accumbens from control and ethanol treated animals 
should be preceded by a more thorough evaluation of potential reference genes in all 
experimental groups, as described in the previous chapter.    
That said, basal D2 expression of NinTV4 in nucleus accumbens was significantly 
greater than B6 expression.  This was accompanied by similar trends towards higher D2 
expression of total Nin, Nin variants 2 and 3 together, and Nin variants 5 and 6 together.  In 
amygdala, B6 expression of NinTV1 was significantly greater than that of D2, while D2 
expression of Nin variants 5 and 6 together was higher than B6.  There was also a small trend 
towards greater expression of NinTV4 in D2 amygdala versus B6.  First, it is important to verify 
that the expression of these transcript variants does correspond to expression of the associated 
proteins which can be verified by western blot.  While the general function of known Ninein 
isoforms 1 through 3 is minus-end microtubule anchoring to the centrosome (Bouckson-
Castaing et al., 1996; Mogensen et al., 2000), there is little known about the differences in 
function or localization, if any, between these 3 isoforms.  Assuming gene expression and 
protein expression are directly related, the expression differences of Nin variants 2 and 3 
(Ninein isoform 2) and variant 4 (Ninein isoform 3) contrasted with the differences in NinTV1 
expression (Ninein isoform 1) in both NAc and amygdala provides a basis for the hypothesis 
that there is some functional difference between the isoforms.  Because Nin transcript variants 
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1-4 were initially observed in fibroblasts (Bouckson-Castaing et al., 1996; Mogensen et al., 
2000), then characterized in epithelial cells (Moss et al., 2007), and cortical neural progenitor 
cells and post-mitotic neurons (Zhang et al., 2016) during embryonic development, it is difficult 
to elucidate implications regarding strain differences in these transcripts in adults without further 
cell-specific experiments.   
 Prior to the experiments in this chapter, the only evidence of Nin transcript variants 5 
(TV5) and 6 (TV6) was confined to embryonic cortical neurons in vitro (Zhang et al., 2016).  
While the difference in expression of NinTV5,6 relative to NinTV6 suggests, at a minimum, the 
presence of TV5, the data presented do not directly confirm this.  Sequencing of the amplified 
product of NinTV6, however, does directly confirm the presence of this transcript despite it being 
labeled as a target for nonsense mediated decay (NMD) in the most recent version of the 
mouse genome (GRCm38.p6, 2017).  Although it is possible that the NinTV5,6 and NinTV6 
products we see in these qPCR experiments are just present prior to being removed via NMD, 
Putman et al. (2016) suggests otherwise.  A western blot in nucleus accumbens using an 
antibody that binds to Ninein isoforms 1-3, and what would be the predicted protein products of 
NinTV 5 and 6 shows more than the three bands that would be expected if known Ninein 
isoforms were the only proteins translated from existing transcripts.  In this blot, there are two 
visible bands between 117KDa and 170KDa that could correspond to the predicted molecular 
weight of the protein product of NinTV6 (~147KDa) labeled NIN4 and NIN5.  Further, D2 mice 
have significantly higher levels of both of these provisional proteins, which parallels the higher 
levels of NinTV5,6 observed in NAc.  Evaluation of strain differences in NinTV6 expression in 
NAc via qPCR and sequencing of the proteins at bands NIN4 and NIN5 are needed to further 
validate this theory. 
Because we know that peptides resembling Nin variants 5 and 6 are unique to 
differentiated neurons (Zhang et al., 2016), higher expression of these variants in D2 mice could 
imply either a greater quantity of neurons or a greater potential for plasticity in existing neurons.  
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In amygdala, the significant difference in expression of NinTV5,6 versus the lack of significance 
in expression of NinTV6 alone suggests that a majority of the difference observed results from 
differences in expression of NinTV5.  Since NinTV6 is a splice variant of NinTV5, it is impossible 
to quantify NinTV5 directly using qPCR with a single fluorophore; multiplex qPCR would be 
better suited for this task.  Splicing of the "large exon" of NinTV5 to form NinTV6 results in 
dissociation of Ninein from the centrosome and diffuse localization throughout the cytoplasm.  
This also highlights the importance of the ratio of NinTV5 to NinTV6.  If there is a higher quantity 
of NinTV5 relative to NinTV6, and this ratio is larger in D2 mice than in B6 mice, this suggests a 
greater potential for either quick axonal outgrowth and branching in nascent adult neurons, or a 
greater potential for synaptic plasticity in D2 mice due to increased stabilization of microtubules 
in newly formed dendritic spines or axon terminals.  In these scenarios, NinTV5 would act as a 
readily available precursor for NinTV6 that is spliced and translated upon cellular responses to a 
stimulus that result in the formation of new synapses or neurons guided by microtubule 
outgrowth and stabilization.  It would be interesting to look at expression of known Ninein 
transcription and splice factors such as Sip1 and Qki5, respectively (Hayakawa-Yano & Yano, 
2019; Srivatsa et al., 2015) in order to shed more light on whether NinTV6 in adult NAc and 
amygdala plays a role in adult neurogenesis or in synaptic plasticity in postmitotic neurons.   
Validating Ninein as a quantitative trait gene for ethanol-induced anxiolytic-like behavior 
will require characterization of Nin transcript variant expression in nucleus accumbens before 
and at different time points after restraint stress, ethanol exposure, and both.  It will also require 
validation of the NIN4 and NIN5 sequence.  In addition, incorporating female mice into these 
experiments is pertinent given the sex and sex*strain effects on anxiety-like behavior in certain 
BXD strains with and without an acute dose of ethanol (Putman, 2008).  One study in rats 
identified different light-dark transition-related behavioral QTL not only between sexes, but also 
across estrous cycle stages (Izídio et al., 2011), which raises the possibility that Etanq1 may not 
be reproducible in female mice of the same BXD strains.  This suggests that female anxiolytic-
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like response to ethanol may be mediated by a different and/or more complicated mechanism 
than occurs in males. 
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Appendix 1 qPCR Temperature Gradient Protocols 
 
Ndufv1F2/R2, Ublcp1 F2/R2, Ublcp1F3/R3, Ublcp1 F4/R4 
 
 
 
Canx F2/R2, Canx F3/R3, Sort1 F2/R2 
 
Denaturation 
Annealing 
Extension 
Denaturation 
Annealing 
Extension 
Melt Curve 
Melt Curve 
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Appendix 2 Ninein Primer Sequences 
 
Primer Set Forward (5' -> 3') Reverse (5' -> 3') 
NinEx5,6,7 TGGTTTCCATCTGCGAACAG CATCGAAAGACTGCATAGAGAGA 
NinEX16,17 AGTTAGGCAAAAAGACGCCC AGCTTTTCAGATTCATATCTCAGGA 
NinTV1 CTGCCCGAGTTTCAAGAGTC ATTCAGGTCATCTGGGTTCC 
NinTV2,3 ACAGGTGAGACTGGACGAGAA AGCAAAGCCTGTGGTGTGTT 
NinTV4 GAAGAAACAGATGCAGCCCCT TTCAGAGGTGCCCAATCCTTCT 
NinTV6 TCCAGGAGGGAAGATATGAATCTG GGGAGTTCTTTTGGCTGAGTTC 
 
